PD-L1 induced by IFN-γ from tumor-associated macrophages via the JAK/STAT3 and PI3K/AKT signaling pathways promoted progression of lung cancer
Xiaohui Zhang(Soochow University), Jian-An Huang(Soochow University), Zeyi Liu(Soochow University), Jianjie Zhu(Soochow University), Yuanyuan Zeng(Sichuan University), Nan Zhang(Huazhong University of Science and Technology), Cheng Chen(Soochow University), Hui Zeng(Zhejiang Cancer Hospital), Weiwei Ning(Soochow University), Qiu‐Xia Qu(Soochow University), Wenwen Du(Indiana University Bloomington)
Cited by 315
Related Papers
Glioma targeted therapy: insight into future of molecular approaches
|Molecular Cancer|2022|727
Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
|Journal of Experimental & Clinical Cancer Research|2021|535
The EGFR pathway is involved in the regulation of PD-L1 expression via the IL-6/JAK/STAT3 signaling pathway in EGFR-mutated non-small cell lung cancer
|International Journal of Oncology|2016|385
Circular RNA hsa_circ_0008305 (circPTK2) inhibits TGF-β-induced epithelial-mesenchymal transition and metastasis by controlling TIF1γ in non-small cell lung cancer
|Molecular Cancer|2018|369
JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells
|International Journal of Oncology|2014|314